Search research articles
Contact Us
Filters
Showing results (231-240 of 327) with videos related to
Page
of 33
Sort By:
The Journal of Clinical Psychiatry
|
May 3, 2006
Outcomes of late-life anxiety disorders during 32 weeks of citalopram treatment
Stephen Blank, Eric J Lenze, Benoit H Mulsant, et al.
Neuropsychiatric Disease and Treatment
|
July 28, 2011
Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia
Tiffany W Chow, Ariel Graff-Guerrero, Nicolaas Plg Verhoeff, et al.
Archives of Internal Medicine
|
February 11, 2004
Paroxetine-induced hyponatremia in older adults: a 12-week prospective study
Tanya J Fabian, Janet A Amico, Patricia D Kroboth, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
July 14, 2004
Executive functioning, illness course, and relapse/recurrence in continuation and maintenance treatment of late-life depression: is there a relationship?
Meryl A Butters, Rishi K Bhalla, Benoit H Mulsant, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
November 28, 2015
A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitation
Ayman Akil, Robert R Bies, Bruce G Pollock, et al.
Journal of Clinical Psychopharmacology
|
November 25, 2010
Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults
Eric J Lenze, Alison M Goate, Petra Nowotny, et al.
Schizophrenia Research
|
February 5, 2022
Decision tree classification of cognitive functions with D<sub>2</sub> receptor occupancy and illness severity in late-life schizophrenia
Keisuke Kusudo, Ryo Ochi, Shinichiro Nakajima, et al.
Journal of Clinical Pharmacology
|
October 21, 2009
Effect of age, weight, and CYP2C19 genotype on escitalopram exposure
Yuyan Jin, Bruce G Pollock, Ellen Frank, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
July 22, 2019
Modulation of brain activity with transcranial direct current stimulation: Targeting regions implicated in impaired illness awareness in schizophrenia
Julia Kim, Eric Plitman, Shinichiro Nakajima, et al.
JAMA
|
January 22, 2009
Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial
Eric J Lenze, Bruce L Rollman, M Katherine Shear, et al.
Page
of 33
Search research articles
Search
Showing results (231-240 of 327) with videos related to
Sort By:
Page
of 33
The Journal of Clinical Psychiatry
|
May 3, 2006
Outcomes of late-life anxiety disorders during 32 weeks of citalopram treatment
Stephen Blank, Eric J Lenze, Benoit H Mulsant, et al.
Neuropsychiatric Disease and Treatment
|
July 28, 2011
Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia
Tiffany W Chow, Ariel Graff-Guerrero, Nicolaas Plg Verhoeff, et al.
Archives of Internal Medicine
|
February 11, 2004
Paroxetine-induced hyponatremia in older adults: a 12-week prospective study
Tanya J Fabian, Janet A Amico, Patricia D Kroboth, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
July 14, 2004
Executive functioning, illness course, and relapse/recurrence in continuation and maintenance treatment of late-life depression: is there a relationship?
Meryl A Butters, Rishi K Bhalla, Benoit H Mulsant, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
November 28, 2015
A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitation
Ayman Akil, Robert R Bies, Bruce G Pollock, et al.
Journal of Clinical Psychopharmacology
|
November 25, 2010
Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults
Eric J Lenze, Alison M Goate, Petra Nowotny, et al.
Schizophrenia Research
|
February 5, 2022
Decision tree classification of cognitive functions with D<sub>2</sub> receptor occupancy and illness severity in late-life schizophrenia
Keisuke Kusudo, Ryo Ochi, Shinichiro Nakajima, et al.
Journal of Clinical Pharmacology
|
October 21, 2009
Effect of age, weight, and CYP2C19 genotype on escitalopram exposure
Yuyan Jin, Bruce G Pollock, Ellen Frank, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
July 22, 2019
Modulation of brain activity with transcranial direct current stimulation: Targeting regions implicated in impaired illness awareness in schizophrenia
Julia Kim, Eric Plitman, Shinichiro Nakajima, et al.
JAMA
|
January 22, 2009
Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial
Eric J Lenze, Bruce L Rollman, M Katherine Shear, et al.
Page
of 33